ECO Animal Health Regulatory Approval
December 19 2017 - 1:00AM
UK Regulatory
TIDMEAH
19 December 2017
ECO Animal Health Group plc
(AIM: EAH)
ECO RECEIVES MARKETING AUTHORISATION FOR AIVLOSIN® FOR CHICKENS
LAYING EGGS FOR HUMAN CONSUMPTIONIN THE PHILIPPINES
ECO Animal Health Group plc (the "Group") is pleased to announce
that its subsidiary ECO Animal Health Limited (ECO) has received a
marketing authorisation from the Animal Feeds, Veterinary Drugs and
Biologics Control Division of the Bureau of Animal Industry of the
Department of Agriculture in the Republic of the Philippines for
the use of Aivlosin® 625 mg/g water soluble granules in chickens
laying eggs for human consumption.
This approval allows ECO to start selling Aivlosin® in the
Philippines for the medication of drinking water for the treatment
of infections caused by Mycoplasma in poultry laying eggs for human
consumption, with a zero day drug withdrawal period for eggs.
ECO has begun the process of submitting the EU approved
Aivlosin® regulatory files for the treatment of layers in numerous
other key egg producing markets.
Aivlosin ® , ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
Peter Lawrence, Chairman of ECO, commented "The Philippines is
the fourth most important egg producing country in South East Asia
and is ranked seventeenth globally for commercial layers. This
latest approval demonstrates ECO's continued progress towards
becoming a major force in the international market for veterinary
pharmaceutical products for livestock."
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900
N+1 Singer (Joint Broker) 020 7496 3000
Mark Taylor, Brough Ransom
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders
View source version on
businesswire.com:http://www.businesswire.com/news/home/20171218005815/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
December 19, 2017 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024